8/29/2025Hengrui's SHR2554 Receives Conditional NMPA Approval

8/29/2025MagicRNA Raises ~CNY 100M in Pre-A+ Financing to Advance HN2301 Thera...

8/27/2025Tibet Rhodiola Bets Big on Cutting-Edge Gene-Editing Pioneer AccurEdit...

8/27/2025CRO ChemPartner to Open New Boston Research Hub in September

8/27/2025Royalty Pharma Targets China's Biotech Market with Early-Stage Investm...

8/27/2025Global Pharma Funnels $48.5B into Chinese Biotech Partnerships in H120...

8/27/2025AstraZeneca Bounces Back from Scandal in China with $2.5B R&D Push

8/26/2025InxMed Advances in Oncology with Upcoming IPO and Promising Pipeline

8/26/2025Simcere's Daridorexant Phase III Data Published and Approved in China

8/26/2025Akeso's Dual Phase III Victories Highlight Expansion of Non-Oncology T...

8/26/2025Akeso's Ivonescimab Secures First Demonstrated OS Benefit in Lung Can...

8/25/2025BeOne Nets Up to $950M in Royalty Deal for Amgen’s Lung Cancer Drug

8/25/2025HemaCell Receives FDA IND Approval for Megakaryocyte Therapy

8/25/2025Minova Secures Over ¥100M in Series B Financing Led by IDG Capital

8/23/2025Recent Executive Moves

8/22/2025NMPA Approves AZ/Daiichi Sankyo's Datopotamab Deruxtecan

8/22/2025InxMed Secures Over $34M in Series C Financing to Advance Oncology Pip...

8/22/2025Premier Li Visits BeOne, Signaling China's Strategic Push for Biotech ...

8/21/2025Henlius Biotech Expands Oncology Portfolio with Strategic Licensing Ag...

8/21/2025Bio-Thera Solutions Taps STADA to Bring BAT1806 to Global Markets

8/21/2025NMPA Lifts Import Suspension on Vasudha's Loratadine API

8/21/2025China Intensifies Biotech Support Amid Surge in Global Licensing Deals

8/20/2025China Drives Asia-Pacific Health Care Transformation Amid Rising Costs...

8/19/2025CANbridge Announces Strategic Partnership and Investment from Baheal 

8/19/2025BioNTech's BNT327 Shows Strong Phase II Results as China-Originated Dr...

8/19/2025RemeGen and Santen Enter into Licensing Deal for Ophthalmic Drug RC28-...

8/19/2025Innovent Presents Phase 2 Study of Tarlatamab in Third-Line ES-SCLC at...

8/19/2025China Unveils Nine Key Healthcare Insurance Priorities for 2025

8/19/2025CSPC Pharma Advances in Biosimilars with Dupilumab Injection Approval

8/19/2025Eisai Launches First Orexin Receptor Antagonist for Insomnia in China

Page:2/367 Total number of articles:10986: [First][<<] [1] [2] [3] [4] [5] [>>] [End]